Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy

Nicholas Funderburg, Ying Jiang, Sara M. Debanne, Danielle Labbato, Steven Juchnowski, Brian Ferrari, Brian Clagett, Janet Robinson, Michael M. Lederman, Grace A. McComsey

JAIDS Journal of Acquired Immune Deficiency Syndromes · 2014 · 158 citations · 43 references

DOIFull text

Open access

Abstract

Forty-eight weeks of rosuvastatin treatment reduced significantly several markers of inflammation and lymphocyte and monocyte activation in ART-treated subjects.

References

43